Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Assets: 2024-2025

Historic Assets for Kura Oncology (KURA) over the last 2 years, with Sep 2025 value amounting to $649.4 million.

  • Kura Oncology's Assets rose 35.62% to $649.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $649.4 million, marking a year-over-year increase of 35.62%. This contributed to the annual value of $760.2 million for FY2024, which is N/A change from last year.
  • Latest data reveals that Kura Oncology reported Assets of $649.4 million as of Q3 2025, which was down 4.84% from $682.4 million recorded in Q2 2025.
  • In the past 5 years, Kura Oncology's Assets ranged from a high of $760.2 million in Q4 2024 and a low of $478.8 million during Q3 2024.
  • Moreover, its 2-year median value for Assets was $649.4 million (2025), whereas its average is $626.2 million.
  • Data for Kura Oncology's Assets shows a peak YoY soared of 35.62% (in 2025) over the last 5 years.
  • Quarterly analysis of 2 years shows Kura Oncology's Assets stood at $760.2 million in 2024, then spiked by 35.62% to $649.4 million in 2025.
  • Its last three reported values are $649.4 million in Q3 2025, $682.4 million for Q2 2025, and $743.8 million during Q1 2025.